Maravai Lifesciences Holdings (MRVI) EPS (Diluted) (2020 - 2026)

Maravai Lifesciences Holdings (MRVI) EPS (Diluted) (2020 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 4.31
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 12.23
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 7.33
4 Revolution Medicines 43.64 Bn 43.64 Bn - -3.06
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 0.16
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 0.00
7 Royalty Pharma 33.72 Bn 35.84 Bn - 0.15
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 1.19
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -0.06
10 Maravai Lifesciences Holdings 1.48 Bn 1.56 Bn 20.65 Mn -0.15

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.15
Mar 31, 2026 -0.04
Dec 31, 2025 -0.44
Sep 30, 2025 -0.31
Jun 30, 2025 -0.48
Mar 31, 2025 -0.37
Dec 31, 2024 -0.33
Sep 30, 2024 -1.22
Jun 30, 2024 -0.14
Mar 31, 2024 -0.17
Dec 31, 2023 -0.83
Sep 30, 2023 -0.11
Jun 30, 2023 -0.09
Mar 31, 2023 -0.01
Dec 31, 2022 0.34
Sep 30, 2022 0.76
Jun 30, 2022 0.61
Mar 31, 2022 0.58
Dec 31, 2021 0.49
Sep 30, 2021 0.51